首页> 外文OA文献 >The Application of NHEJ-CRISPR/Cas9 and Cre-Lox System in the Generation of Bivalent Duck Enteritis Virus Vaccine against Avian Influenza Virus
【2h】

The Application of NHEJ-CRISPR/Cas9 and Cre-Lox System in the Generation of Bivalent Duck Enteritis Virus Vaccine against Avian Influenza Virus

机译:NHEJ-CRISPR / CAS9和CRE-LOX系统在对禽流感病毒生成二价鸭炎病毒疫苗中的应用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Duck-targeted vaccines to protect against avian influenza are critically needed to aid in influenza disease control efforts in regions where ducks are endemic for highly pathogenic avian influenza (HPAI). Duck enteritis virus (DEV) is a promising candidate viral vector for development of vaccines targeting ducks, owing to its large genome and narrow host range. The clustered regularly interspaced palindromic repeats (CRISPR)/Cas9 system is a versatile gene-editing tool that has proven beneficial for gene modification and construction of recombinant DNA viral vectored vaccines. Currently, there are two commonly used methods for gene insertion: non-homologous end-joining (NHEJ) and homology-directed repair (HDR). Owing to its advantages in efficiency and independence from molecular requirements of the homologous arms, we utilized NHEJ-dependent CRISPR/Cas9 to insert the influenza hemagglutinin (HA) antigen expression cassette into the DEV genome. The insert was initially tagged with reporter green fluorescence protein (GFP), and a Cre-Lox system was later used to remove the GFP gene insert. Furthermore, a universal donor plasmid system was established by introducing double bait sequences that were independent of the viral genome. In summary, we provide proof of principle for generating recombinant DEV viral vectored vaccines against the influenza virus using an integrated NHEJ-CRISPR/Cas9 and Cre-Lox system.
机译:为了防止禽流感的鸭肉针对性疫苗,旨在帮助在鸭子流动的地区对高病原禽流感(HPAI)的地区进行流感疾病控制努力。鸭肠炎病毒(DEV)是一个有希望的候选病毒载体,用于瞄准鸭子的疫苗,由于其大的基因组和狭窄的宿主范围。聚集经常间隙的回文重复(CRISPR)/ CAS9系统是一种多功能的基因编辑工具,其已被证明是有益的基因改性和重组DNA病毒疫苗的构建。目前,有两种常用的基因插入方法:非同源终端连接(NHEJ)和同源导向的修复(HDR)。由于其优于效率和同源臂的分子要求的优点,我们利用NHEJ依赖性CRISPR / CAS9将流感血凝素(HA)抗原表达盒插入DEV基因组。初始标记插入件,记者绿色荧光蛋白(GFP)标记,后来使用CRE-LOX系统来除去GFP基因插入物。此外,通过引入与病毒基因组无关的双诱饵序列来建立普遍的供体质粒系统。总之,我们提供了使用集成的NHEJ-CRISPR / CAS9和CRE-LOX系统产生针对流感病毒的重组Dev病毒疫苗的原理证据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号